3rd Breast and Gynecological International Cancer Conference

- , Cairo, Egypt

Hlavní témata:

  • Biology-Driven Selection of Adjuvant/Neoadjuvant Therapy of Primary Breast Cancer.
  • State of the Art Anti-HER2 Therapy for Breast Cancer.
  • Multidisciplinary Management of Metastatic Breast Cancer.
  • The Concept of Personalised Medicine : is Breast Cancer the New Target ?
  • State of the Art in the Adjuvant Chemotherapy in Breast Cancer: When to Use and When Not?
  • Management of Triple Negative Breast Cancer Including PARP Inhibitors.
  • Management of Women Who are at Increased Risk of Breast Cancer.
  • Emerging Targeted Therapies in Breast Cancer .
  • Primary Systemic Therapy in Breast Cancer: Novel Molecular Concepts.
  • Sentinel Node Before and After Neoadjuvant Therapy.
  • Decision Factors for Adjuvant Chemotherapy.
  • Selection of Hormonal Treatment for Postmenopausal Breast Cancer Patients.
  • What are Adequate Margins with Breast Conserving Therapy?
  • Reconstruction Pros and Cons of Immediate Versus Delayed When Radiation is Necessary.
  • Contact X-ray Applications in Breast and Gynecological Malignancies.
  • HDR Interstitial Brachytherapy in Breast Cancer for Local Recurence After Initial Conservative Treatment.
  • Do we Need to Reoperate the Positive SNB and Prognostic Value of the I+ and Micrometastatic SNB.
  • Value of Hepatic Metastatectomy in Stage IV Breast Cancer .
  • Partial Breast Radiation.
  • Minimizing Local Recurrence: What is Proven and What is Not?
  • HER2 Testing in Breast Cancer: Pitfalls.
  • Recent Advances in HPV Research.
  • New ASCCP Guidelines for the Management of Abnormal Pap Smear and Staging Advances in Gynecologic Cancers.
  • Can we Blame Genes in the ERBB2 Amplicon for Trastuzumab Resistance?
  • Cutting Edge of Breast Imaging with Mammography, Utrasound and Breast MRI.
  • International Cooperation in the Field of Modern Oncology : Is It Only Useful for Long-Term Research or for the Practical Care of Egyptian Patients ?
  • Cyperknife Value in Breast Cancer.

Aktivní účast

Registrace

Program

Web: http://www.bgicc.e.../experts-2011.html

  • Přidat do kalendáře: 2011-01-13 00:00:00 2011-01-14 23:59:59 Europe/Prague 3rd Breast and Gynecological International Cancer Conference Hlavní témata: Biology-Driven Selection of Adjuvant/Neoadjuvant Therapy of Primary Breast Cancer. State of the Art Anti-HER2 Therapy for Breast Cancer. Multidisciplinary Management of Metastatic Breast Cancer. The Concept of Personalised Medicine : is Breast Cancer the New Target ? State of the Art in the Adjuvant Chemotherapy in Breast Cancer: When to Use and When Not? Management of Triple Negative Breast Cancer Including PARP Inhibitors. Management of Women Who are at Increased Risk of Breast Cancer. Emerging Targeted Therapies in Breast Cancer . Primary Systemic Therapy in Breast Cancer: Novel Molecular Concepts. Sentinel Node Before and After Neoadjuvant Therapy. Decision Factors for Adjuvant Chemotherapy. Selection of Hormonal Treatment for Postmenopausal Breast Cancer Patients. What are Adequate Margins with Breast Conserving Therapy? Reconstruction Pros and Cons of Immediate Versus Delayed When Radiation is Necessary. Contact X-ray Applications in Breast and Gynecological Malignancies. HDR Interstitial Brachytherapy in Breast Cancer for Local Recurence After Initial Conservative Treatment. Do we Need to Reoperate the Positive SNB and Prognostic Value of the I+ and Micrometastatic SNB. Value of Hepatic Metastatectomy in Stage IV Breast Cancer . Partial Breast Radiation. Minimizing Local Recurrence: What is Proven and What is Not? HER2 Testing in Breast Cancer: Pitfalls. Recent Advances in HPV Research. New ASCCP Guidelines for the Management of Abnormal Pap Smear and Staging Advances in Gynecologic Cancers. Can we Blame Genes in the ERBB2 Amplicon for Trastuzumab Resistance? Cutting Edge of Breast Imaging with Mammography, Utrasound and Breast MRI. International Cooperation in the Field of Modern Oncology : Is It Only Useful for Long-Term Research or for the Practical Care of Egyptian Patients ? Cyperknife Value in Breast Cancer. Cairo, Egypt